drugset / Trial / NCT01871701

Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs

NCT01871701

RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the corrected QT interval change(automatic-reading) after single oral administration of escitalopram, quetiapine and moxifloxacin versus placebo in healthy Korean Adults.

Timeline

Start
2012-11
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg Oral
Subject Moxifloxacin Small molecule 400 mg Oral
Subject Quetiapine Small molecule 100 mg Oral

Indications

No indication recorded.